Market Research Report
Nutrigenomics Market Size, Share & Trends Analysis Report By Application (Obesity, Cardiovascular Diseases, Cancer Research), By Region (North America, Latin America, Europe, MEA, APAC), And Segment Forecasts, 2019 - 2025
|Nutrigenomics Market Size, Share & Trends Analysis Report By Application (Obesity, Cardiovascular Diseases, Cancer Research), By Region (North America, Latin America, Europe, MEA, APAC), And Segment Forecasts, 2019 - 2025|
Published: January 31, 2019
Grand View Research, Inc.
Content info: 80 Pages
Delivery time: 2-10 business days
The global nutrigenomics market size is expected to reach USD 850.86 million by 2025 registering a CAGR of 16.48%, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising cases of obesity and Cardiovascular Diseases (CVDs), particularly in developed regions. Nutrigenomics can play a vital role in the prevention of obesity by offering personalized, gene-based diet. Increased awareness about the product along with growing geriatric population will also augment the market growth.
Obesity and cancer research applications of nutrigenomics emerged as the market leaders in 2017 and are expected to maintain the dominance expanding at a significant CAGR over the forecast period. Developing regional markets including Asia Pacific, Latin America, and Middle East are also expected to witness rapid expansion owing to the increased cases of obesity and growing geriatric population.
The global nutrigenomics demand exceeded USD 250 million in 2017 and is expected to expand at a CAGR of 16.48% over the forecast period
Obesity application segment led the market in 2017 and is estimated to account for a 38% of the industry share by 2025
North America accounted for the largest market share in 2017 and is estimated to maintain its dominance over the years to come
The Asia Pacific market is projected to witness substantial growth over the next decade owing to increasing cases of obesity and CVD-related deaths
Key participants in the global nutrigenomics market include Koninklijke DSM N.V. (Royal DSM); BASF SE; Danone; GeneSmart; Unilever; Genova Diagnostics; Inc.; Nutrigenomix, Inc.; Metagenics, Inc.; WellGen, Inc.; and Cell Logic